Veterinary Medicine Information website

Eurican DAPPi-LR vakcina

Not authorised
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Rabies virus, Inactivated
  • Canine parvovirus, Live
  • Canine parainfluenza virus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Download as PDF

Product identification

Medicine name:
Eurican DAPPi-LR vakcina
Active substance:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Rabies virus, Inactivated
  • Canine parvovirus, Live
  • Canine parainfluenza virus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    40.00
    Hamster protective Dose 80%
    /
    1.00
    unit(s)/dose
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
    40.00
    Hamster protective Dose 80%
    /
    1.00
    unit(s)/dose
  • Rabies virus, Inactivated
    1.00
    international unit(s)
    /
    1.00
    unit(s)/dose
  • Canine parvovirus, Live
    4.90
    log10 50% tissue culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine parainfluenza virus, Live
    4.70
    log10 50% tissue culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine adenovirus 2, Live
    2.50
    log10 50% tissue culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine distemper virus, Live
    4.00
    log10 50% tissue culture infectious dose
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Powder and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: